Association of Time to Kidney Transplantation With Graft Failure Among US Patients With End-Stage Renal Disease Due to Lupus Nephritis

被引:36
|
作者
Plantinga, Laura C. [1 ,2 ]
Patzer, Rachel E. [3 ,4 ]
Drenkard, Cristina [4 ]
Kramer, Michael R. [1 ]
Klein, Mitchel [1 ]
Lim, S. Sam [4 ]
McClellan, William M. [1 ]
Pastan, Stephen O. [3 ,4 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[2] Emory Univ, Laney Grad Sch, Atlanta, GA 30322 USA
[3] Emory Healthcare, Emory Transplant Ctr, Atlanta, GA USA
[4] Emory Univ, Sch Med, Atlanta, GA 30322 USA
关键词
HEALTH DISPARITIES; OUTCOMES; RECIPIENTS; MORTALITY; DIALYSIS; ACCESS; GUIDELINES;
D O I
10.1002/acr.22482
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveProviders recommend waiting to transplant patients with end-stage renal disease (ESRD) secondary to lupus nephritis (LN), to allow for quiescence of systemic lupus erythematosus (SLE)-related immune activity. However, these recommendations are not standardized, and we sought to examine whether duration of time to transplant was associated with risk of graft failure in US LN-ESRD patients. MethodsUsing national ESRD surveillance data (United States Renal Data System), we identified 4,743 US patients with LN-ESRD who received a first transplant on or after January 1, 2000 (followup through September 30, 2011). The association of wait time (time from ESRD start to transplant) with graft failure was assessed with Cox proportional hazards models, with splines of the exposure to allow for nonlinearity of the association and with adjustment for potential confounding by demographic, clinical, and transplant factors. ResultsWhite LN-ESRD patients who were transplanted later (versus at <3 months receiving dialysis) were at increased risk of graft failure (3-12 months: adjusted hazard ratio [HR] 1.23, 95% confidence interval [95% CI] 0.93-1.63; 12-24 months: adjusted HR 1.37, 95% CI 0.92-2.06; 24-36 months: adjusted HR 1.34, 95% CI 0.92-1.97; and >36 months: adjusted HR 1.98, 95% CI 1.31-2.99). However, no such association was seen among African American recipients (3-12 months: adjusted HR 1.07, 95% CI 0.79-1.45; 12-24 months: adjusted HR 1.01, 95% CI 0.64-1.60; 24-36 months: adjusted HR 0.78, 95% CI 0.51-1.18; and >36 months: adjusted HR 0.74, 95% CI 0.48-1.13). ConclusionWhile future studies are needed to examine the potential confounding effect of clinically recognized SLE activity on the observed associations, these results suggest that longer wait times to transplant may be associated with equivalent or worse, not better, graft outcomes among LN-ESRD patients.
引用
收藏
页码:571 / 581
页数:11
相关论文
共 50 条
  • [31] Simultaneous heart and kidney transplantation in patients with end-stage heart and renal failure
    Leeser, DB
    Jeevanandam, V
    Furukawa, S
    Eisen, H
    Mather, P
    Silva, P
    Guy, S
    Foster, CE
    AMERICAN JOURNAL OF TRANSPLANTATION, 2001, 1 (01) : 89 - 92
  • [32] RESULTS OF KIDNEY TRANSPLANTATION IN PATIENTS WITH END-STAGE RENAL FAILURE CAUSED BY AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Daineko, V. S.
    Ananiev, A. N.
    Nevirovich, E. S.
    Skvorcov, A. E.
    Budylev, S. A.
    Selivanov, A. N.
    Moskalenko, M. M.
    Manukovskiy, V. A.
    Reznik, O. N.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2019, 21 (02): : 39 - 48
  • [33] END-STAGE RENAL-FAILURE IN SYSTEMIC LUPUS-ERYTHEMATOSUS WITH NEPHRITIS
    CORREIA, P
    CAMERON, JS
    OGG, CS
    WILLIAMS, DG
    BEWICK, M
    HICKS, JA
    CLINICAL NEPHROLOGY, 1984, 22 (06) : 293 - 302
  • [34] The impact of renal transplantation on the incidence of congestive heart failure in patients with end-stage renal disease due to diabetes
    Abbott, KC
    Hypolite, IO
    Hshieh, P
    Cruess, D
    Agodoa, LYC
    Welch, PG
    Taylor, AJ
    Yuan, CM
    JOURNAL OF NEPHROLOGY, 2001, 14 (05) : 369 - 376
  • [35] PATTERNS OF GRIEF - END-STAGE RENAL FAILURE AND KIDNEY TRANSPLANTATION
    CHRISTOPHERSON, LK
    GONDA, TA
    JOURNAL OF THANATOLOGY, 1975, 3 (01): : 49 - 57
  • [36] Sociodemographic and Geographic Predictors of Quality of Care in United States Patients With End-Stage Renal Disease Due to Lupus Nephritis
    Plantinga, Laura C.
    Drenkard, Cristina
    Patzer, Rachel E.
    Klein, Mitchel
    Kramer, Michael R.
    Pastan, Stephen
    Lim, S. Sam
    McClellan, William M.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (03) : 761 - 772
  • [37] Renal deposits of complement factors as predictors of end-stage renal disease and death in patients with lupus nephritis
    Koopman, Jacob J. E.
    Rennke, Helmut G.
    Leatherwood, Cianna
    Speyer, Cameron B.
    D'Silva, Kristin
    McMahon, Gearoid M.
    Waikar, Sushrut S.
    Costenbader, Karen H.
    RHEUMATOLOGY, 2020, 59 (12) : 3751 - 3758
  • [38] Outcome of Kidney Transplantation Following End-Stage Renal Disease Due to Reflux Nephropathy
    Yazici, H.
    Caliskan, Y.
    Ozturk, S.
    Ozkan, O.
    Turkmen, A.
    Sever, M. S.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (05) : 1566 - 1569
  • [39] Variation in renal biopsy and medication prescribing practices among pediatric Medicaid patients with lupus nephritis prior to end-stage renal disease in the US, 2000 to 2004
    LT Hiraki
    CH Feldman
    J Liu
    GS Alarcón
    MA Fischer
    WC Winkelmayer
    KH Costenbader
    Arthritis Research & Therapy, 14 (Suppl 3):
  • [40] Variation in renal biopsy and medication prescribing practices among pediatric Medicaid patients with lupus nephritis prior to end-stage renal disease in the US, 2000 to 2004
    Hiraki, L. T.
    Feldman, C. H.
    Liu, J.
    Alarcon, G. S.
    Fischer, M. A.
    Winkelmayer, W. C.
    Costenbader, K. H.
    ARTHRITIS RESEARCH & THERAPY, 2012, 14